Literature DB >> 16564675

The psychosocial consequences of BOTOX injections for spasmodic dysphonia: a qualitative study of patients' experiences.

Carolyn R Baylor1, Kathryn M Yorkston, Tanya L Eadie, Nicole C Maronian.   

Abstract

OBJECTIVES/HYPOTHESIS: The purpose of this study is to examine the psychosocial consequences of BOTOX (Allergan, Inc. Irvine, CA) treatment for spasmodic dysphonia (SD). This article also explores how patients judge the success of treatment and make decisions about future treatment based on psychosocial issues relevant to them. STUDY
DESIGN: This study follows the phenomenological tradition of qualitative inquiry in which the objective is to explore the lived experiences of a group of persons who share a common phenomenon, in this case receiving BOTOX injections for SD.
METHODS: Six adults with SD who had been receiving BOTOX injections on a long-term basis participated in face-to-face interviews. The interviews were recorded, transcribed, and analyzed according to phenomenological guidelines to identify consistent themes as well as differences among participants' experiences.
RESULTS: The results are summarized in three primary themes that suggest (1) participants' experiences vary over time based on changes in factors such as lifestyle and personal priorities; (2) BOTOX has multidimensional psychosocial implications in physical, personal, and social domains; and (3) participants individualize their treatment regimens, taking into consideration the burden of treatment, scheduling priorities, and other strategies to maximize the benefits of BOTOX.
CONCLUSIONS: Based on this study, suggestions are provided for future research into a psychosocial outcome measurement, including longitudinal evaluations that accommodate changing patient priorities over time; multidimensional evaluations that incorporate physical, personal, and social issues; evaluations that include a measure of the burden of treatment; and evaluations that support a shared decision-making model with the voice clinicians.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564675      PMCID: PMC2649951          DOI: 10.1016/j.jvoice.2006.01.007

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  37 in total

1.  Adductor spasmodic dysphonia and botulinum toxin treatment: the effect on well-being.

Authors:  T P Langeveld; F Luteijn; M van Rossum; H A Drost; R J Baatenburg de Jong
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-10       Impact factor: 1.547

Review 2.  Shared decision making: developing the OPTION scale for measuring patient involvement.

Authors:  G Elwyn; A Edwards; M Wensing; K Hood; C Atwell; R Grol
Journal:  Qual Saf Health Care       Date:  2003-04

3.  Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.

Authors:  M S Benninger; G Gardner; C Grywalski
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-09

4.  Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia.

Authors:  Steven Bielamowicz; Sheila V Stager; Andrea Badillo; Alexis Godlewski
Journal:  J Voice       Date:  2002-03       Impact factor: 2.009

5.  Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia.

Authors:  S Bielamowicz; S Squire; K Bidus; C L Ludlow
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-05       Impact factor: 1.547

6.  Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes.

Authors:  R P Mehta; S N Goldman; L A Orloff
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-04

7.  Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.

Authors:  N D Hogikyan; W P Wodchis; C Spak; P R Kileny
Journal:  J Voice       Date:  2001-12       Impact factor: 2.009

8.  Acoustic measures of symptoms in abductor spasmodic dysphonia.

Authors:  J D Edgar; C M Sapienza; K Bidus; C L Ludlow
Journal:  J Voice       Date:  2001-09       Impact factor: 2.009

9.  Use of qualitative research to analyze patient and clinician decision making in carotid endarterectomy.

Authors:  Josephine Gibson
Journal:  J Vasc Nurs       Date:  2002-06

10.  Botox treatment in adductor spasmodic dysphonia: a meta-analysis.

Authors:  Frank Boutsen; Michael P Cannito; Merlin Taylor; Brenda Bender
Journal:  J Speech Lang Hear Res       Date:  2002-06       Impact factor: 2.297

View more
  8 in total

1.  Dynamics of phonatory posturing at phonation onset.

Authors:  Travis L Shiba; Dinesh K Chhetri
Journal:  Laryngoscope       Date:  2015-12-21       Impact factor: 3.325

2.  Achieving Participation-Focused Intervention Through Shared Decision Making: Proposal of an Age- and Disorder-Generic Framework.

Authors:  Carolyn Baylor; Meghan Darling-White
Journal:  Am J Speech Lang Pathol       Date:  2020-05-28       Impact factor: 2.408

3.  Alcohol responsiveness in laryngeal dystonia: a survey study.

Authors:  Diana N Kirke; Steven J Frucht; Kristina Simonyan
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

4.  Developing the communicative participation item bank: Rasch analysis results from a spasmodic dysphonia sample.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie; Robert M Miller; Dagmar Amtmann
Journal:  J Speech Lang Hear Res       Date:  2009-08-28       Impact factor: 2.297

5.  Communicative participation restrictions in multiple sclerosis: associated variables and correlation with social functioning.

Authors:  Kathryn M Yorkston; Carolyn Baylor; Dagmar Amtmann
Journal:  J Commun Disord       Date:  2014-05-26       Impact factor: 2.288

Review 6.  Living with, managing and minimising treatment burden in long term conditions: a systematic review of qualitative research.

Authors:  Sara Demain; Ana-Carolina Gonçalves; Carlos Areia; Rúben Oliveira; Ana Jorge Marcos; Alda Marques; Ranj Parmar; Katherine Hunt
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

Review 7.  Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature.

Authors:  Adem Sav; Asiyeh Salehi; Frances S Mair; Sara S McMillan
Journal:  BMC Med Res Methodol       Date:  2017-09-12       Impact factor: 4.615

8.  Selection process for botulinum toxin injections in patients with chronic-stage hemiplegic stroke: a qualitative study.

Authors:  Sawako Arai; Yuko Fukase; Akira Okii; Yoshimi Suzukamo; Toshimitsu Suga
Journal:  BMC Med Inform Decis Mak       Date:  2019-12-19       Impact factor: 2.796

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.